SHOT

SHOT

Safety Shot Inc. Common Stock

$0.243+-0.000 (-0.000%)

实时价格

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$0.243

最高价

$0.243

最低价

$0.243

成交量

1.60M

公司基本面

交易统计

AI分析报告

最后更新: 2025年5月29日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

SHOT: Safety Shot Inc. Common Stock – Unpacking Recent Developments and Future Prospects

Stock Symbol: SHOT Generate Date: 2025-05-29 08:05:28

Alright, let's break down what's been happening with Safety Shot Inc. and what the numbers might be telling us.

The Latest Buzz: News Sentiment

The news flow around Safety Shot has been pretty upbeat lately. We're seeing a clear positive vibe, mainly driven by the company's acquisition of Yerbaé.

  • Big Partnership: Just a couple of days ago, on May 27th, news dropped about Yerbaé partnering with Guckenheimer, a national foodservice provider. This is a big deal because it means Yerbaé's functional drinks, and by extension Safety Shot's reach after the merger, are getting into a lot more cafes and markets across the country. More distribution usually means more sales.
  • Growth Expectations: Earlier in May, specifically on the 23rd, Safety Shot announced that acquiring Yerbaé is expected to boost their annual revenue by a whopping 1000% over 2024. That's a massive projection and certainly gets attention.
  • Market Trend Alignment: There's also commentary highlighting a broader shift in the beverage market. People are increasingly looking for "functional" drinks – stuff that does more than just quench thirst, like gut health or recovery. Both Yerbaé and Safety Shot fit right into this trend, which suggests a favorable market environment for their products.

So, the overall feeling from the news is quite positive, focusing on expanded reach and significant revenue growth potential post-merger.

What the Stock Price Has Been Doing

Looking at the past few months, SHOT's price has seen its ups and downs.

  • Recent Dip: If we zoom in on the last month or so, the stock has generally been on a downward slide from around $0.54 at the start of May to its recent close of $0.35 on May 28th. There was a notable jump on April 25th and 28th, but that momentum didn't hold.
  • Volume Spike: Interestingly, on May 28th, the trading volume absolutely exploded, hitting nearly 9.7 million shares. That's way, way higher than its average volume of about 1.2 million. This kind of volume, especially on a down day, can signal a lot of activity – perhaps some significant selling pressure, or maybe even a capitulation event where sellers are exhausted.
  • Current Price vs. Trend: The current price of $0.35 is sitting near the lower end of its 52-week range ($0.339 to $1.77). It's also below its 20-day moving average, which points to recent downward momentum.

Now, the AI's short-term predictions are a bit mixed but lean slightly positive for the day after tomorrow:

  • Today's Prediction: 0.00% (essentially flat)
  • Next Day's Prediction: -0.10% (a tiny dip)
  • The Day after Next Day's Prediction: +0.86% (a small bounce)

These short-term AI predictions don't show a dramatic immediate rebound, despite the positive news.

Putting It All Together: Outlook & Strategy Ideas

This is where it gets interesting. We have very positive news about growth and market alignment, but the stock price has been trending down, with a recent high-volume dip.

  • Apparent Near-Term Leaning: The situation seems to be a bit of a tug-of-war. The strong positive news, especially the Guckenheimer partnership and the 1000% revenue growth projection, suggests a potential for future appreciation. However, the recent price action and high volume on a down day indicate that the market hasn't fully digested or reacted positively to this news yet, or there's underlying selling pressure. The AI's short-term predictions are quite modest, not showing an immediate surge. This might suggest a "hold" or "accumulate on weakness" stance for those who believe in the long-term story.

  • Potential Entry Consideration: Given the current price is near its 52-week low and the news is fundamentally strong, this could be an interesting area for those looking at a medium-term position (1-3 months), as suggested by the AI. The AI's recommendation data points to potential entry around $0.41 to $0.42. If the stock can stabilize or show signs of bouncing from its current low, perhaps around the $0.38-$0.40 mark (which was a recent open/close level), that might be a spot to consider. The idea here is to potentially catch it before the market fully prices in the positive merger news.

  • Potential Exit/Stop-Loss Consideration: For managing risk, a stop-loss around $0.36 is suggested by the AI's analysis. This would be just below recent lows and could help limit potential losses if the downward trend continues despite the positive news. On the upside, the AI projects a potential target price of $1.00, which is a significant jump from current levels. A shorter-term take-profit level could be around $0.441, which aligns with some of the AI's technical indicators.

Company Context

Safety Shot Inc. is a small company (market cap around $26 million) in the "Beverages - Non-Alcoholic" sector. They're known for their "Safety Shot Beverage" which lowers blood alcohol content, and now, with the Yerbaé acquisition, they're expanding significantly into functional beverages. This means the news about partnerships and market shifts in functional drinks is incredibly relevant to their core business and future prospects. Their small size also means they can be quite sensitive to market news and trading volume.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and you could lose money. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions.

相关新闻

GlobeNewswire

Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise

Company to Expand Patented Wellness Approach into High-Growth Cognitive and Restorative Sleep Markets, Emphasizing Scientific Rigor and Unique Formulations SCOTTSDALE, AZ, June 03, 2025 (GLOBE NEWSWIRE) -- Safety

查看更多
Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise
GlobeNewswire

Yerbaé Partners with National Foodservice Provider, Guckenheimer

New partnership brings Yerbaé's functional beverages to Guckenheimer's national café & market business and expands reach for Safety Shot at the conclusion of the companies' merger SCOTTSDALE, Ariz., May 27, 2025

查看更多
Yerbaé Partners with National Foodservice Provider, Guckenheimer
PR Newswire

From Gut Health to Recovery Drinks, This Category Is Just Getting Started

Equity Insider News Commentary – As consumer preferences continue to shift, refreshment is no longer just about quenching thirst—it's increasingly...

查看更多
From Gut Health to Recovery Drinks, This Category Is Just Getting Started
GlobeNewswire

Safe Shot to Capitalize on Yerbae's Strong Retail Presence & Distributor Network Following Acquisition

Acquisition expected to increase Safety Shot annual revenue by 1000 percent over 2024 SCOTTSDALE, Ariz., May 23, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (NASDAQ:SHOT) ("SHOT", "Safety Shot", or the "Company"),

查看更多
Safe Shot to Capitalize on Yerbae's Strong Retail Presence & Distributor Network Following Acquisition
PR Newswire

The $600B Beverage Shift: Why Function Is Outpacing Flavor

Equity Insider News Commentary – In the U.S. and abroad, analysts report that consumer interest in "boosted" drinks—those promising anything from gut ...

查看更多
The $600B Beverage Shift: Why Function Is Outpacing Flavor

AI预测Beta

AI建议

看涨

更新于: 2025年6月12日 22:57

看跌中性看涨

58.9% 置信度

风险与交易

风险等级3/5
中风险
适合于
价值激进
交易指南

入场点

$0.25

止盈点

$0.29

止损点

$0.23

关键因素

PDI 32.9高于MDI 24.5,且ADX 22.2,表明看涨趋势
MACD -0.0003高于信号线-0.0007,表明看涨交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。